Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

628
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
628
Secondary Healthcare System01:11

Secondary Healthcare System

1.6K
Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...
1.6K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
Primary Healthcare Services01:30

Primary Healthcare Services

1.5K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.5K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.3K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

[Is it myasthenia gravis?]

MMW Fortschritte der Medizin·2026
Same author

The Microbial Inhabitants of the Corona Lava Tube: Astrobiological Insights from a Mars Analog Environment.

Astrobiology·2026
Same author

Cellular and humoral vaccination response under immunotherapies-German consensus on vaccination strategies in neurological autoimmune diseases.

Therapeutic advances in neurological disorders·2025
Same author

Internet-based exercise and physical activity promotion for persons with multiple sclerosis: a randomized controlled trial.

BMC sports science, medicine & rehabilitation·2025
Same author

Different Patterns of Autoantibody Secretion by Peripheral Blood Mononuclear Cells in Autoimmune Nodopathies.

Neurology(R) neuroimmunology & neuroinflammation·2024
Same author

TAURUS-MS II: real-world use of teriflunomide in Germany and changes in treatment patterns over time.

Therapeutic advances in neurological disorders·2024

関連する実験動画

Updated: Sep 9, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.2K

[初等医療における多発性硬化症]

Mathias Mäurer

    Deutsche medizinische Wochenschrift (1946)
    |August 29, 2025
    PubMed
    まとめ
    この要約は機械生成です。

    多発性硬化症 (MS) は中枢神経系 (CNS) の慢性炎症性疾患で 世界中で約100万人が罹患しています MSとその治療法を理解することは,初等医療における希少性にもかかわらず,その重大な影響のために,一般医にとって極めて重要です.

    さらに関連する動画

    The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
    11:35

    The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

    Published on: June 30, 2014

    58.1K
    Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
    06:19

    Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

    Published on: September 9, 2022

    3.8K

    関連する実験動画

    Last Updated: Sep 9, 2025

    Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
    08:51

    Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

    Published on: February 19, 2021

    9.2K
    The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
    11:35

    The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

    Published on: June 30, 2014

    58.1K
    Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
    06:19

    Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

    Published on: September 9, 2022

    3.8K

    科学分野:

    • 神経科学
    • 免疫学
    • 流行病学

    背景:

    • 多発性硬化症 (MS) は,中枢神経系 (CNS) に影響する最も一般的な慢性炎症性疾患です.
    • 世界中で約100万人がMSに罹患しており ドイツでは約25万例です
    • この病気は通常,若い成人 (20〜40歳) に発症し,女性の3倍の罹患率で不均衡に発症します.

    研究 の 目的:

    • 多発性硬化症 (MS) の社会医学的な重要性を強調する.
    • 一般医がMSと現在の治療法を理解する重要性を強調する.
    • 基本的ケア環境でMSが比較的珍しいという課題に取り組むこと

    主な方法:

    • MSの流行と人口統計に関する文献レビュー
    • 多発性硬化症の社会医学的な影響の分析
    • 初等医療における診断と治療の検討

    主要な成果:

    • 多発性硬化症は慢性の中枢神経炎症の主要な原因で,世界的にも国内的にも顕著です.
    • 典型的な発症は若い成人期で,女性の発症率が高くなります.
    • 発症率が高いにもかかわらず,一般診療では稀に発症することがあります.

    結論:

    • 一般医は,MS,その疫学,および管理戦略に関する最新の知識を必要とします.
    • MSの認知は早期診断と 効果的な患者のケアに不可欠です
    • この社会医学的に重要な病気の管理には 医療従事者の知識のギャップを埋めることが不可欠です